Viewing Study NCT00138567


Ignite Creation Date: 2025-12-25 @ 12:35 AM
Ignite Modification Date: 2026-01-04 @ 12:38 AM
Study NCT ID: NCT00138567
Status: COMPLETED
Last Update Posted: 2016-11-18
First Post: 2005-08-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Extension to a Study on the Efficacy and Safety of Vildagliptin Compared to Metformin in Drug Naive Patients With Type 2 Diabetes
Sponsor: Novartis
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Diabetes Mellitus, Type 2 View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 diabetes View
None vildagliptin View